CABA vs. SANA

In the year-to-date period, CABA achieves a -88.11% return, which is significantly lower than SANA's -42.65% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Cabaletta Bio, Inc. (CABA) and Sana Biotechnology, Inc. (SANA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CABA Sharpe Ratio is -0.90, which is lower than the SANA Sharpe Ratio of -0.43. The chart below compares the historical Sharpe Ratios of CABA and SANA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CABA nor SANA has paid dividends to shareholders.

The maximum CABA drawdown since its inception was -96.63%, roughly equal to the maximum SANA drawdown of -94.62%. Use the drawdown chart below to compare losses from any high point for CABA and SANA. For additional features, visit the drawdowns tool.

Cabaletta Bio, Inc. (CABA) has a higher volatility of 33.85% compared to Sana Biotechnology, Inc. (SANA) at 18.33%. This indicates that CABA's price experiences larger fluctuations and is considered to be riskier than SANA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Cabaletta Bio, Inc. and Sana Biotechnology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.